New York Life Investment Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

New York Life Investment Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-17,368	Closed	-$1.31M	–	1277
2022 Q2	$1.31M	Buy	+17,368	New	+$772K	0.02%	585

New York Life Investment Management's TPTX Position: Q3 2022 in Review

New York Life Investment Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 17,368 shares — an estimated $1.31M sold.

New York Life Investment Management first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $1.31M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

New York Life Investment Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
New York Life Investment Management sold 17,368 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.31M.
New York Life Investment Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
New York Life Investment Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.31M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on New York Life Investment Management's 13F filing for Q3 2022, filed 10 Nov 2022.